{"transactions":[{"id":739370,"issuer":{"id":6085,"kind":"organization","name":"Neostellar Capital Corp.","symbol":"NSLR"},"owners":[{"id":38609,"kind":"person","name":"Mazur Marc","position":1,"cik":"0001361226","reported_name":"Mazur Marc","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-12T18:55:45.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":3536,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Relates to restricted shares granted under the SuRo Capital Corp. Second Amended and Restated 2019 Equity Incentive Plan, which are scheduled to vest in full on the earlier of (i) the first anniversary of the award date (with such first anniversary being June 10, 2027) and (ii) the date of SuRo Capital Corp.'s annual meeting of stockholders that is closest to the first anniversary of the award date. In connection with the approval of the Company's externalization by its stockholders, the Board of Directors of the Company may, in its sole discretion, accelerate the vesting of these shares."}],"balance_after":68950,"source":{"system":"sec-edgar","filing":"0001493152-26-028554","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1361226/000149315226028554/ownership.xml","form_type":"4"}},{"id":1128988,"issuer":{"id":6085,"kind":"organization","name":"Neostellar Capital Corp.","symbol":"NSLR"},"owners":[{"id":38609,"kind":"person","name":"Mazur Marc","position":1,"cik":"0001361226","reported_name":"Mazur Marc","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-30T17:23:58.000Z","date":"2025-05-28","kind":"grant","planned":false,"acquired":true,"shares":7812,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Relates to restricted shares granted under the SuRo Capital Corp. Second Amended and Restated 2019 Equity Incentive Plan, which vest in full on the earlier of (i) the first anniversary of the award date (with such first anniversary being May 28, 2026) and (ii) the date of SuRo Capital Corp.'s (the \"Company's\") annual meeting of stockholders that is closest to the first anniversary of the award date."}],"balance_after":65414,"source":{"system":"sec-edgar","filing":"0001104659-25-055012","document":"tm2516423-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1361226/000110465925055012/tm2516423-3_4seq1.xml","form_type":"4"}},{"id":1486316,"issuer":{"id":6085,"kind":"organization","name":"Neostellar Capital Corp.","symbol":"NSLR"},"owners":[{"id":38609,"kind":"person","name":"Mazur Marc","position":1,"cik":"0001361226","reported_name":"Mazur Marc","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-07T16:07:56.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":12048,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Relates to restricted shares granted under the SuRo Capital Corp. Amended and Restated 2019 Equity Incentive Plan, which vest in full on the earlier of (i) the first anniversary of the award date (with such first anniversary being June 5, 2025) and (ii) the date of SuRo Capital Corp.'s (the \"Company's\") annual meeting of stockholders that is closest to the first anniversary of the award date."}],"balance_after":57602,"source":{"system":"sec-edgar","filing":"0001104659-24-069638","document":"tm2416744-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1361226/000110465924069638/tm2416744-2_4seq1.xml","form_type":"4"}},{"id":1851652,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":38609,"kind":"person","name":"Mazur Marc","position":1,"cik":"0001361226","reported_name":"Mazur Marc","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T21:02:41.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":277778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted under the 2021 Plan and shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, June 14, 2023, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":277778,"derivative":{"exercise_price":0.7503,"expiration_date":"2033-06-14","underlying":"Class A Common Stock","underlying_shares":277778},"source":{"system":"sec-edgar","filing":"0000899243-23-015879","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1361226/000089924323015879/doc4.xml","form_type":"4"}},{"id":1851651,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":38609,"kind":"person","name":"Mazur Marc","position":1,"cik":"0001361226","reported_name":"Mazur Marc","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2023-06-16T21:02:41.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":199921,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Equity Incentive Plan (the \"2021 Plan\"), with each RSU representing a right to receive one share of the Issuer's Class A common stock.  The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, June 14, 2023, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 199,921 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock.  The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, June 14, 2023, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":236066,"source":{"system":"sec-edgar","filing":"0000899243-23-015879","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1361226/000089924323015879/doc4.xml","form_type":"4"}},{"id":1869214,"issuer":{"id":6085,"kind":"organization","name":"Neostellar Capital Corp.","symbol":"NSLR"},"owners":[{"id":38609,"kind":"person","name":"Mazur Marc","position":1,"cik":"0001361226","reported_name":"Mazur Marc","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-02T20:14:39.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":15015,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Relates to restricted shares granted under the SuRo Capital Corp. Amended and Restated 2019 Equity Incentive Plan, which vest in full on the earlier of (i) the first anniversary of the award date (with such first anniversary being May 31, 2024) and (ii) the date of SuRo Capital Corp.'s (the \"Company's\") annual meeting of stockholders that is closest to the first anniversary of the award date."}],"balance_after":45554,"source":{"system":"sec-edgar","filing":"0001104659-23-067713","document":"tm2317630-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1361226/000110465923067713/tm2317630-3_4seq1.xml","form_type":"4"}},{"id":2206834,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":38609,"kind":"person","name":"Mazur Marc","position":1,"cik":"0001361226","reported_name":"Mazur Marc","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-15T20:54:50.000Z","date":"2022-07-13","kind":"grant","acquired":true,"shares":54152,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is granted under the Issuer's 2021 Plan and shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, July 13, 2022, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":54152,"derivative":{"exercise_price":4.15,"expiration_date":"2032-07-13","underlying":"Class A Common Stock","underlying_shares":54152},"source":{"system":"sec-edgar","filing":"0000899243-22-026194","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1361226/000089924322026194/doc4.xml","form_type":"4"}},{"id":2206833,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":38609,"kind":"person","name":"Mazur Marc","position":1,"cik":"0001361226","reported_name":"Mazur Marc","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-07-15T20:54:50.000Z","date":"2022-07-13","kind":"grant","acquired":true,"shares":36145,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Equity Incentive Plan (the \"2021 Plan\"), with each RSU representing a right to receive one share of the Issuer's Class A common stock.  The RSUs is shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, July 13, 2022, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":36145,"source":{"system":"sec-edgar","filing":"0000899243-22-026194","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1361226/000089924322026194/doc4.xml","form_type":"4"}},{"id":2243981,"issuer":{"id":6085,"kind":"organization","name":"Neostellar Capital Corp.","symbol":"NSLR"},"owners":[{"id":38609,"kind":"person","name":"Mazur Marc","position":1,"cik":"0001361226","reported_name":"Mazur Marc","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-03T12:15:46.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":6684,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Relates to restricted shares granted under the SuRo Capital Corp. Amended and Restated 2019 Equity Incentive Plan, which vest in full on the earlier of (i) the first anniversary of the award date (with such first anniversary being June 1, 2023) and (ii) the date of SuRo Capital Corp.'s (the \"Company's\") annual meeting of stockholders that is closest to the first anniversary of the award date."}],"balance_after":30539,"source":{"system":"sec-edgar","filing":"0001104659-22-067949","document":"tm2217669-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1361226/000110465922067949/tm2217669-3_4seq1.xml","form_type":"4"}},{"id":2571825,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":38609,"kind":"person","name":"Mazur Marc","position":1,"cik":"0001361226","reported_name":"Mazur Marc","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-13T18:11:59.000Z","date":"2021-09-09","kind":"grant","acquired":true,"shares":56053,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, September 9, 2021, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through each such date."}],"balance_after":56053,"derivative":{"exercise_price":6.72,"expiration_date":"2031-09-09","underlying":"Class A Common Stock","underlying_shares":56053},"source":{"system":"sec-edgar","filing":"0001213900-21-047752","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1361226/000121390021047752/ownership.xml","form_type":"4"}},{"id":2634709,"issuer":{"id":6085,"kind":"organization","name":"Neostellar Capital Corp.","symbol":"NSLR"},"owners":[{"id":38609,"kind":"person","name":"Mazur Marc","position":1,"cik":"0001361226","reported_name":"Mazur Marc","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-13T19:05:04.000Z","date":"2021-07-09","kind":"grant","acquired":true,"shares":3770,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Relates to restricted shares granted under the SuRo Capital Corp. Amended and Restated 2019 Equity Incentive Plan, which vest in full on the earlier of the (i) first anniversary of the award date (with such first anniversary being July 9, 2022) and (ii) date of SuRo Capital Corp.'s (the \"Company\") annual meeting of stockholders that is closest to the first anniversary of the award date."},{"field":"shares","element":"transactionShares","label":"F1","text":"Relates to restricted shares granted under the SuRo Capital Corp. Amended and Restated 2019 Equity Incentive Plan, which vest in full on the earlier of the (i) first anniversary of the award date (with such first anniversary being July 9, 2022) and (ii) date of SuRo Capital Corp.'s (the \"Company\") annual meeting of stockholders that is closest to the first anniversary of the award date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This total includes (i) 1,040 shares of the Company's common stock and (ii) 1,147 shares of the Company's common stock acquired in connection with a dividend of the Company."}],"balance_after":17397,"source":{"system":"sec-edgar","filing":"0001104659-21-091811","document":"tm2122112d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1361226/000110465921091811/tm2122112d2_4.xml","form_type":"4"}},{"id":3091057,"issuer":{"id":6085,"kind":"organization","name":"Neostellar Capital Corp.","symbol":"NSLR"},"owners":[{"id":38609,"kind":"person","name":"Mazur Marc","position":1,"cik":"0001361226","reported_name":"Mazur Marc","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-02T17:36:20.000Z","date":"2020-07-02","kind":"grant","acquired":true,"shares":5440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted shares issued under SuRo Capital Corp.'s (the \"Company\") Amended and Restated 2019 Equity Incentive Plan."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Such restricted shares shall vest in full on the first anniversary of the award date (with such first anniversary being July 2, 2021) (or, if earlier, the Company's annual meeting of stockholders that is closest to the first anniversary of the award date)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Such restricted shares shall vest in full on the first anniversary of the award date (with such first anniversary being July 2, 2021) (or, if earlier, the Company's annual meeting of stockholders that is closest to the first anniversary of the award date)."}],"balance_after":11440,"source":{"system":"sec-edgar","filing":"0001104659-20-080695","document":"tm2023968d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1361226/000110465920080695/tm2023968d2_4.xml","form_type":"4"}},{"id":3343065,"issuer":{"id":153085,"kind":"organization","name":"Fibrocell Science, Inc.","symbol":"FCSC"},"owners":[{"id":38609,"kind":"person","name":"Mazur Marc","position":1,"cik":"0001361226","reported_name":"Mazur Marc","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2019-12-13T16:09:35.000Z","date":"2019-12-13","kind":"disposition_to_issuer","acquired":false,"shares":12000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, effective as of immediately prior to the effective time of the merger of the Company and Merger Sub, outstanding options, whether vested or not, became fully vested in accordance with the terms of the Merger Agreement and were canceled in exchange for a cash payment equal to the number of shares of Company common stock underlying the options multiplied by the excess of the per share merger consideration of $3.00 over the per share exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, effective as of immediately prior to the effective time of the merger of the Company and Merger Sub, outstanding options, whether vested or not, became fully vested in accordance with the terms of the Merger Agreement and were canceled in exchange for a cash payment equal to the number of shares of Company common stock underlying the options multiplied by the excess of the per share merger consideration of $3.00 over the per share exercise price."}],"balance_after":0,"derivative":{"exercise_price":1.94,"expiration_date":"2029-06-12","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001628280-19-015073","document":"wf-form4_157627135662849.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/357097/000162828019015073/wf-form4_157627135662849.xml","form_type":"4"}},{"id":3343064,"issuer":{"id":153085,"kind":"organization","name":"Fibrocell Science, Inc.","symbol":"FCSC"},"owners":[{"id":38609,"kind":"person","name":"Mazur Marc","position":1,"cik":"0001361226","reported_name":"Mazur Marc","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2019-12-13T16:09:35.000Z","date":"2019-12-13","kind":"disposition_to_issuer","acquired":false,"shares":6000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, effective as of immediately prior to the effective time of the merger of the Company and Merger Sub, outstanding options, whether vested or not, became fully vested in accordance with the terms of the Merger Agreement and were canceled in exchange for a cash payment equal to the number of shares of Company common stock underlying the options multiplied by the excess of the per share merger consideration of $3.00 over the per share exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, effective as of immediately prior to the effective time of the merger of the Company and Merger Sub, outstanding options, whether vested or not, became fully vested in accordance with the terms of the Merger Agreement and were canceled in exchange for a cash payment equal to the number of shares of Company common stock underlying the options multiplied by the excess of the per share merger consideration of $3.00 over the per share exercise price."}],"balance_after":0,"derivative":{"exercise_price":2.36,"expiration_date":"2028-06-19","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001628280-19-015073","document":"wf-form4_157627135662849.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/357097/000162828019015073/wf-form4_157627135662849.xml","form_type":"4"}},{"id":3343063,"issuer":{"id":153085,"kind":"organization","name":"Fibrocell Science, Inc.","symbol":"FCSC"},"owners":[{"id":38609,"kind":"person","name":"Mazur Marc","position":1,"cik":"0001361226","reported_name":"Mazur Marc","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2019-12-13T16:09:35.000Z","date":"2019-12-13","kind":"disposition_to_issuer","acquired":false,"shares":6000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, effective as of immediately prior to the effective time of the merger of the Company and Merger Sub, outstanding options, whether vested or not, became fully vested in accordance with the terms of the Merger Agreement and were canceled in exchange for a cash payment equal to the number of shares of Company common stock underlying the options multiplied by the excess of the per share merger consideration of $3.00 over the per share exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, effective as of immediately prior to the effective time of the merger of the Company and Merger Sub, outstanding options, whether vested or not, became fully vested in accordance with the terms of the Merger Agreement and were canceled in exchange for a cash payment equal to the number of shares of Company common stock underlying the options multiplied by the excess of the per share merger consideration of $3.00 over the per share exercise price."}],"balance_after":0,"derivative":{"exercise_price":16.55,"expiration_date":"2027-06-22","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001628280-19-015073","document":"wf-form4_157627135662849.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/357097/000162828019015073/wf-form4_157627135662849.xml","form_type":"4"}},{"id":3343062,"issuer":{"id":153085,"kind":"organization","name":"Fibrocell Science, Inc.","symbol":"FCSC"},"owners":[{"id":38609,"kind":"person","name":"Mazur Marc","position":1,"cik":"0001361226","reported_name":"Mazur Marc","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2019-12-13T16:09:35.000Z","date":"2019-12-13","kind":"disposition_to_issuer","acquired":false,"shares":2400,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, effective as of immediately prior to the effective time of the merger of the Company and Merger Sub, outstanding options, whether vested or not, became fully vested in accordance with the terms of the Merger Agreement and were canceled in exchange for a cash payment equal to the number of shares of Company common stock underlying the options multiplied by the excess of the per share merger consideration of $3.00 over the per share exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, effective as of immediately prior to the effective time of the merger of the Company and Merger Sub, outstanding options, whether vested or not, became fully vested in accordance with the terms of the Merger Agreement and were canceled in exchange for a cash payment equal to the number of shares of Company common stock underlying the options multiplied by the excess of the per share merger consideration of $3.00 over the per share exercise price."}],"balance_after":0,"derivative":{"exercise_price":14.25,"expiration_date":"2026-06-22","underlying":"Common Stock","underlying_shares":2400},"source":{"system":"sec-edgar","filing":"0001628280-19-015073","document":"wf-form4_157627135662849.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/357097/000162828019015073/wf-form4_157627135662849.xml","form_type":"4"}},{"id":3343061,"issuer":{"id":153085,"kind":"organization","name":"Fibrocell Science, Inc.","symbol":"FCSC"},"owners":[{"id":38609,"kind":"person","name":"Mazur Marc","position":1,"cik":"0001361226","reported_name":"Mazur Marc","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2019-12-13T16:09:35.000Z","date":"2019-12-13","kind":"disposition_to_issuer","acquired":false,"shares":2400,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, effective as of immediately prior to the effective time of the merger of the Company and Merger Sub, outstanding options, whether vested or not, became fully vested in accordance with the terms of the Merger Agreement and were canceled in exchange for a cash payment equal to the number of shares of Company common stock underlying the options multiplied by the excess of the per share merger consideration of $3.00 over the per share exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, effective as of immediately prior to the effective time of the merger of the Company and Merger Sub, outstanding options, whether vested or not, became fully vested in accordance with the terms of the Merger Agreement and were canceled in exchange for a cash payment equal to the number of shares of Company common stock underlying the options multiplied by the excess of the per share merger consideration of $3.00 over the per share exercise price."}],"balance_after":0,"derivative":{"exercise_price":81.6,"expiration_date":"2025-06-24","underlying":"Common Stock","underlying_shares":2400},"source":{"system":"sec-edgar","filing":"0001628280-19-015073","document":"wf-form4_157627135662849.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/357097/000162828019015073/wf-form4_157627135662849.xml","form_type":"4"}},{"id":3343060,"issuer":{"id":153085,"kind":"organization","name":"Fibrocell Science, Inc.","symbol":"FCSC"},"owners":[{"id":38609,"kind":"person","name":"Mazur Marc","position":1,"cik":"0001361226","reported_name":"Mazur Marc","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2019-12-13T16:09:35.000Z","date":"2019-12-13","kind":"disposition_to_issuer","acquired":false,"shares":1200,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, effective as of immediately prior to the effective time of the merger of the Company and Merger Sub, outstanding options, whether vested or not, became fully vested in accordance with the terms of the Merger Agreement and were canceled in exchange for a cash payment equal to the number of shares of Company common stock underlying the options multiplied by the excess of the per share merger consideration of $3.00 over the per share exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, effective as of immediately prior to the effective time of the merger of the Company and Merger Sub, outstanding options, whether vested or not, became fully vested in accordance with the terms of the Merger Agreement and were canceled in exchange for a cash payment equal to the number of shares of Company common stock underlying the options multiplied by the excess of the per share merger consideration of $3.00 over the per share exercise price."}],"balance_after":0,"derivative":{"exercise_price":62.1,"expiration_date":"2024-06-20","underlying":"Common Stock","underlying_shares":1200},"source":{"system":"sec-edgar","filing":"0001628280-19-015073","document":"wf-form4_157627135662849.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/357097/000162828019015073/wf-form4_157627135662849.xml","form_type":"4"}},{"id":3343059,"issuer":{"id":153085,"kind":"organization","name":"Fibrocell Science, Inc.","symbol":"FCSC"},"owners":[{"id":38609,"kind":"person","name":"Mazur Marc","position":1,"cik":"0001361226","reported_name":"Mazur Marc","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2019-12-13T16:09:35.000Z","date":"2019-12-13","kind":"disposition_to_issuer","acquired":false,"shares":1600,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, effective as of immediately prior to the effective time of the merger of the Company and Merger Sub, outstanding options, whether vested or not, became fully vested in accordance with the terms of the Merger Agreement and were canceled in exchange for a cash payment equal to the number of shares of Company common stock underlying the options multiplied by the excess of the per share merger consideration of $3.00 over the per share exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, effective as of immediately prior to the effective time of the merger of the Company and Merger Sub, outstanding options, whether vested or not, became fully vested in accordance with the terms of the Merger Agreement and were canceled in exchange for a cash payment equal to the number of shares of Company common stock underlying the options multiplied by the excess of the per share merger consideration of $3.00 over the per share exercise price."}],"balance_after":0,"derivative":{"exercise_price":82.35,"expiration_date":"2023-07-19","underlying":"Common Stock","underlying_shares":1600},"source":{"system":"sec-edgar","filing":"0001628280-19-015073","document":"wf-form4_157627135662849.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/357097/000162828019015073/wf-form4_157627135662849.xml","form_type":"4"}},{"id":3343058,"issuer":{"id":153085,"kind":"organization","name":"Fibrocell Science, Inc.","symbol":"FCSC"},"owners":[{"id":38609,"kind":"person","name":"Mazur Marc","position":1,"cik":"0001361226","reported_name":"Mazur Marc","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2019-12-13T16:09:35.000Z","date":"2019-12-13","kind":"disposition_to_issuer","acquired":false,"shares":534,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, effective as of immediately prior to the effective time of the merger of the Company and Merger Sub, outstanding options, whether vested or not, became fully vested in accordance with the terms of the Merger Agreement and were canceled in exchange for a cash payment equal to the number of shares of Company common stock underlying the options multiplied by the excess of the per share merger consideration of $3.00 over the per share exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, effective as of immediately prior to the effective time of the merger of the Company and Merger Sub, outstanding options, whether vested or not, became fully vested in accordance with the terms of the Merger Agreement and were canceled in exchange for a cash payment equal to the number of shares of Company common stock underlying the options multiplied by the excess of the per share merger consideration of $3.00 over the per share exercise price."}],"balance_after":0,"derivative":{"exercise_price":52.5,"expiration_date":"2023-02-21","underlying":"Common Stock","underlying_shares":534},"source":{"system":"sec-edgar","filing":"0001628280-19-015073","document":"wf-form4_157627135662849.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/357097/000162828019015073/wf-form4_157627135662849.xml","form_type":"4"}},{"id":3343057,"issuer":{"id":153085,"kind":"organization","name":"Fibrocell Science, Inc.","symbol":"FCSC"},"owners":[{"id":38609,"kind":"person","name":"Mazur Marc","position":1,"cik":"0001361226","reported_name":"Mazur Marc","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2019-12-13T16:09:35.000Z","date":"2019-12-13","kind":"disposition_to_issuer","acquired":false,"shares":534,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, effective as of immediately prior to the effective time of the merger of the Company and Merger Sub, outstanding options, whether vested or not, became fully vested in accordance with the terms of the Merger Agreement and were canceled in exchange for a cash payment equal to the number of shares of Company common stock underlying the options multiplied by the excess of the per share merger consideration of $3.00 over the per share exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, effective as of immediately prior to the effective time of the merger of the Company and Merger Sub, outstanding options, whether vested or not, became fully vested in accordance with the terms of the Merger Agreement and were canceled in exchange for a cash payment equal to the number of shares of Company common stock underlying the options multiplied by the excess of the per share merger consideration of $3.00 over the per share exercise price."}],"balance_after":0,"derivative":{"exercise_price":232.5,"expiration_date":"2021-01-14","underlying":"Common Stock","underlying_shares":534},"source":{"system":"sec-edgar","filing":"0001628280-19-015073","document":"wf-form4_157627135662849.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/357097/000162828019015073/wf-form4_157627135662849.xml","form_type":"4"}},{"id":3343056,"issuer":{"id":153085,"kind":"organization","name":"Fibrocell Science, Inc.","symbol":"FCSC"},"owners":[{"id":38609,"kind":"person","name":"Mazur Marc","position":1,"cik":"0001361226","reported_name":"Mazur Marc","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2019-12-13T16:09:35.000Z","date":"2019-12-13","kind":"disposition_to_issuer","acquired":false,"shares":534,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, effective as of immediately prior to the effective time of the merger of the Company and Merger Sub, outstanding options, whether vested or not, became fully vested in accordance with the terms of the Merger Agreement and were canceled in exchange for a cash payment equal to the number of shares of Company common stock underlying the options multiplied by the excess of the per share merger consideration of $3.00 over the per share exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, effective as of immediately prior to the effective time of the merger of the Company and Merger Sub, outstanding options, whether vested or not, became fully vested in accordance with the terms of the Merger Agreement and were canceled in exchange for a cash payment equal to the number of shares of Company common stock underlying the options multiplied by the excess of the per share merger consideration of $3.00 over the per share exercise price."}],"balance_after":0,"derivative":{"exercise_price":390,"expiration_date":"2020-04-01","underlying":"Common Stock","underlying_shares":534},"source":{"system":"sec-edgar","filing":"0001628280-19-015073","document":"wf-form4_157627135662849.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/357097/000162828019015073/wf-form4_157627135662849.xml","form_type":"4"}},{"id":3343055,"issuer":{"id":153085,"kind":"organization","name":"Fibrocell Science, Inc.","symbol":"FCSC"},"owners":[{"id":38609,"kind":"person","name":"Mazur Marc","position":1,"cik":"0001361226","reported_name":"Mazur Marc","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-13T16:09:35.000Z","date":"2019-12-13","kind":"disposition_to_issuer","acquired":false,"shares":600,"price":3,"value":1800.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of September 12, 2019 (the \"Merger Agreement\"), among Fibrocell Science, Inc. (the \"Company\"), Castle Creek Pharmaceutical Holdings, Inc. and Castle Creek Merger Corp., effective as of immediately prior to the effective time of the merger of the Company and Merger Sub, these shares of Company common stock were converted into the right to receive a cash payment equal to the per share merger consideration of $3.00."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001628280-19-015073","document":"wf-form4_157627135662849.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/357097/000162828019015073/wf-form4_157627135662849.xml","form_type":"4"}},{"id":3490628,"issuer":{"id":153085,"kind":"organization","name":"Fibrocell Science, Inc.","symbol":"FCSC"},"owners":[{"id":38609,"kind":"person","name":"Mazur Marc","position":1,"cik":"0001361226","reported_name":"Mazur Marc","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2019-06-14T16:33:13.000Z","date":"2019-06-12","kind":"grant","acquired":true,"shares":12000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were issued in connection with the reporting person's service to the Company as a member of its Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"50% of the shares vest and become exercisable on the earlier of (x) June 12, 2020 and (y) the date of the Company's 2020 Annual Meeting of Stockholders, and the remaining 50% of the shares vest and become exercisable on the earlier of (x) June 12, 2021 and (y) the date of the Company's 2021 Annual Meeting of Stockholders, in each case, subject to the grantee's continued service through the applicable vesting dates."}],"balance_after":12000,"derivative":{"exercise_price":1.94,"expiration_date":"2029-06-12","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001628280-19-008007","document":"wf-form4_156054437858719.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/357097/000162828019008007/wf-form4_156054437858719.xml","form_type":"4"}},{"id":3886632,"issuer":{"id":153085,"kind":"organization","name":"Fibrocell Science, Inc.","symbol":"FCSC"},"owners":[{"id":38609,"kind":"person","name":"Mazur Marc","position":1,"cik":"0001361226","reported_name":"Mazur Marc","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2018-06-21T16:12:11.000Z","date":"2018-06-19","kind":"grant","acquired":true,"shares":6000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were issued in connection with the reporting person's service to the Company as a member of its Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"50% of the shares vest and become exercisable on the earlier of (x) June 19, 2019 and (y) the date of the Company's 2019 Annual Meeting of Stockholders, and the remaining 50% of the shares vest and become exercisable on the earlier of (x) June 19, 2020 and (y) the date of the Company's 2020 Annual Meeting of Stockholders, in each case, subject to the grantee's continued service through the applicable vesting dates."}],"balance_after":6000,"derivative":{"exercise_price":2.36,"expiration_date":"2028-06-19","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001628280-18-008179","document":"wf-form4_152961191400063.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/357097/000162828018008179/wf-form4_152961191400063.xml","form_type":"4"}},{"id":4235046,"issuer":{"id":6085,"kind":"organization","name":"Neostellar Capital Corp.","symbol":"NSLR"},"owners":[{"id":38609,"kind":"person","name":"Mazur Marc","position":1,"cik":"0001361226","reported_name":"Mazur Marc","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2017-08-14T20:26:07.000Z","date":"2017-08-14","kind":"purchase","acquired":true,"shares":6000,"price":4.45,"value":26700.0,"ownership":{"direct":true},"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001144204-17-043321","document":"v473332_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1361226/000114420417043321/v473332_4.xml","form_type":"4"}},{"id":4272991,"issuer":{"id":153085,"kind":"organization","name":"Fibrocell Science, Inc.","symbol":"FCSC"},"owners":[{"id":38609,"kind":"person","name":"Mazur Marc","position":1,"cik":"0001361226","reported_name":"Mazur Marc","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2017-06-26T19:34:23.000Z","date":"2017-06-22","kind":"grant","acquired":true,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were issued in connection with the reporting person's employment service to the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"50% of the shares vest and become exercisable on the earlier of (x) June 22, 2018 and (y) the date of the Company's 2018 Annual Meeting of Stockholders, and the remaining 50% of the shares vest and become exercisable on the earlier of (x) June 22, 2019 and (y) the date of the Company's 2019 Annual Meeting of Stockholders, in each case, subject to the grantee's continued service through the applicable vesting dates."}],"balance_after":30000,"derivative":{"exercise_price":3.31,"expiration_date":"2027-06-22","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001628280-17-006736","document":"wf-form4_149852004936184.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/357097/000162828017006736/wf-form4_149852004936184.xml","form_type":"4"}}]}